STE Pharmacueticals at Arab Health 2025

STE Pharmacueticals at Arab Health 2025

Taking Healthcare Innovation to the Next Level 

Healthcare and medical technology are constantly evolving, and Arab Health 2025 is where the most innovative ideas come to life. As one of the most influential events in the industry, it brings together global leaders to explore the trends shaping the future of healthcare. 

At STE Pharmaceuticals, we are driven by innovation and reliability. This dedication leads us to showcase our most advanced solutions at Arab Health, all designed to improve lives and meet the needs of a dynamic global market, especially in the Arab region, which is key for growth and expansion in the healthcare sector. The importance of this market lies not only in its rapid evolution but also in its role as a reference for new opportunities for collaboration and investment in healthcare technologies. 

From cutting-edge medical devices to nutritional supplements, every product we develop reflects our passion for excellence and our commitment to delivering top-quality solutions. 

Beyond presenting our innovations, Arab Health offers a unique platform to connect with industry professionals, exchange knowledge, and strengthen strategic partnerships. This event underscores our position as a key player in the global healthcare sector. 

Join us on this journey toward the future of healthcare. Follow us on social media for updates and visit our booth at Arab Health 2025 to see how we are leading the way in healthcare innovation. 

🗓️ January 27–30, 2025 
📍 Booth RB19 

STE Pharmaceuticals obtains the EU-MDR Certificate

STE Pharmaceuticals obtains the EU-MDR Certificate

STE Pharmaceuticals obtains the EU-MDR Certificate

STE Pharmaceuticals is one of the first companies to obtain EU-MDR CERTIFICATE

Medical Devices in EU are currently governed by the Medical Devices Regulation (EU) 2017/745 of the European Parliament and of the council of 5 April 2017 on medical devices (Medical Device Regulation, or “MDR”) from May 26th, 2021. New medical devices developments should already be focused at complying with the MDR requirements.

The medical devices’s manufacturers have a transition period until May 26, 2024 to certify all those devices that are currently certified by the previous Directive 93/42/CEE or MDD, called Medical Device Legacy.

STE Pharmaceuticals obtained at the end of 2020 the first certification under MDR in Europe for cough syrups devices and currently has more than 20 references certified under MDR, being a pioneer company in this regard.

STE Pharmaceuticals currently has the following categories of medical devices certified under MDR:

In 2020

Medical devices in liquid form for the treatment of cough: a complete range of cough syrups based on cane sugar, gums and natural plant extracts, suitable for adults and children from 1 year.

In 2020

Sprays solution for nasal irrigation: nasal sprays based on sea water and purified water with different salts concentrations, formats and spray strengths, indicated for daily cleaning and nasal decongestion, to cover all the user’s needs from birth.

In 2020

Nasal sprays based on sea water and purified waterwith natural plant extracts, indicated for nasal decongestion. Plant extracts aid and prolong the moisturizing power of sea water and provide a pleasant and fresh aroma.

In 2020

Nasal sprays based on saline solution with propolisand natural plant extracts, indicated in pathological processes as rhinitis, excessive secretions, flu and catarrhal processes.

Do you want to know more?
Get in touch!

    Name *

    Company

    Phone number

    * Required fields
    I accept the Privacy Policy.